Published in
BioMed Central, Arthritis Research and Therapy, 1(18)
DOI: 10.1186/s13075-016-1094-y
Links
Tools
The 5-HT1A receptor agonist buspirone improves esophageal motor function and symptoms in systemic sclerosis: a 4-week, open-label trial
Journal article published in 2016 by
George P. Karamanolis,
Stylianos Panopoulos 
,
Konstantinos Denaxas,
Anastasios Karlaftis,
Alexandra Zorbala,
Dimitrios Kamberoglou,
Spiros D. Ladas,
Petros P. Sfikakis
,
Konstantinos Denaxas,
Anastasios Karlaftis,
Alexandra Zorbala,
Dimitrios Kamberoglou,
Spiros D. Ladas,
Petros P. Sfikakis
This paper is made freely available by the publisher.
Full text: Download
Data provided by 